​

Funding Round

Series B - Abridge

Series B - Abridge

Investment Firm

Overview

Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.

Announced Date

Oct 26, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Spark Capital

Spark Capital

Spark Capital is a debt and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorLifePoint Health
Participant InvestorMayo Clinic
Participant InvestorKaiser Permanente Ventures
Participant InvestorBessemer Venture Partners
Participant InvestorSpark Capital

Round Details and Background

Abridge raised $30000000 on 2023-10-26 in Series B

Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 11, 2022
Series A - Abridge
7-12.5M
May 18, 2023
Corporate Round - Abridge
1-undefined
Oct 26, 2023
Series B - Abridge
9-30.0M
Feb 23, 2024
Series C - Abridge
10-150.0M

Recent Activity

There is no recent news or activity for this profile.